User profiles for Kohshin Washiyama
Kohshin WashiyamaFukushima Medical University Verified email at fmu.ac.jp Cited by 741 |
Production and supply of α-particle–emitting radionuclides for targeted α-therapy
…, H Yang, JA Osso, K Washiyama… - Journal of nuclear …, 2021 - Soc Nuclear Med
Encouraging results from targeted α-therapy have received significant attention from academia
and industry. However, the limited availability of suitable radionuclides has hampered …
and industry. However, the limited availability of suitable radionuclides has hampered …
αvβ3 Integrin‐targeting radionuclide therapy and imaging with monomeric RGD peptide
M Yoshimoto, K Ogawa, K Washiyama… - … journal of cancer, 2008 - Wiley Online Library
The α v β 3 integrin plays a pivotal role in angiogenesis and tumor metastasis. Angiogenic
blood vessels overexpress α v β 3 integrin, as in tumor neovascularization, and α v β 3 …
blood vessels overexpress α v β 3 integrin, as in tumor neovascularization, and α v β 3 …
Development of probes for radiotheranostics with albumin binding moiety to increase the therapeutic effects of astatine-211 (211At)
…, M Munekane, T Fuchigami, K Washiyama… - European Journal of …, 2024 - Springer
Purpose We have developed probes for multiradionuclides radiotheranostics using RGD
peptide ([ 67 Ga]Ga-DOTA-c[RGDf(4-I)K] ([ 67 Ga]1) and Ga-DOTA-[ 211 At]c[RGDf(4-At)K] ([ …
peptide ([ 67 Ga]Ga-DOTA-c[RGDf(4-I)K] ([ 67 Ga]1) and Ga-DOTA-[ 211 At]c[RGDf(4-At)K] ([ …
68Ga- and 211At-Labeled RGD Peptides for Radiotheranostics with Multiradionuclides
…, K Mishiro, S Hirata, K Washiyama… - Molecular …, 2021 - ACS Publications
Probes for radiotheranostics could be produced by introducing radionuclides with similar
chemical characteristics into the same precursors. We recently developed an 211 At-labeled …
chemical characteristics into the same precursors. We recently developed an 211 At-labeled …
Development of [90Y] DOTA-conjugated bisphosphonate for treatment of painful bone metastases
K Ogawa, H Kawashima, K Shiba, K Washiyama… - Nuclear medicine and …, 2009 - Elsevier
INTRODUCTION: Based on the concept of bifunctional radiopharmaceuticals, we have
previously developed 186 Re-complex-conjugated bisphosphonate analogs for palliation of …
previously developed 186 Re-complex-conjugated bisphosphonate analogs for palliation of …
227Th-EDTMP: A potential therapeutic agent for bone metastasis
K Washiyama, R Amano, J Sasaki, S Kinuya… - Nuclear medicine and …, 2004 - Elsevier
The biodistribution of 227 Th-EDTMP and retention of its daughter nuclide 223 Ra were
examined. Th-EDTMP was found to show high uptake and long-term retention in bone. The …
examined. Th-EDTMP was found to show high uptake and long-term retention in bone. The …
Evaluation of radioiodinated vesamicol analogs for sigma receptor imaging in tumor and radionuclide receptor therapy
…, N Akhter, M Yoshimoto, K Washiyama… - Cancer …, 2009 - Wiley Online Library
It has been reported that sigma receptors are highly expressed in a variety of human tumors.
In this study, we selected (+)‐2‐[4‐(4‐iodophenyl)piperidino] cyclohexanol [(+)‐pIV] as a …
In this study, we selected (+)‐2‐[4‐(4‐iodophenyl)piperidino] cyclohexanol [(+)‐pIV] as a …
[HTML][HTML] Assessment of olfactory nerve by SPECT-MRI image with nasal thallium-201 administration in patients with olfactory impairments in comparison to healthy …
Purpose The aim of this study was to assess whether migration of thallium-201 ( 201 Tl) to
the olfactory bulb were reduced in patients with olfactory impairments in comparison to …
the olfactory bulb were reduced in patients with olfactory impairments in comparison to …
Evaluation of the olfactory nerve transport function by SPECT-MRI fusion image with nasal thallium-201 administration
H Shiga, J Taki, M Yamada, K Washiyama… - Molecular imaging and …, 2011 - Springer
Purpose The aim of this study was to visualize the human olfactory transport pathway to the
brain by performing imaging after nasal thallium-201 ( 201 Tl) administration. Procedures …
brain by performing imaging after nasal thallium-201 ( 201 Tl) administration. Procedures …
[HTML][HTML] Human dosimetry of free 211At and meta-[211At]astatobenzylguanidine (211At-MABG) estimated using preclinical biodistribution from normal mice
N Ukon, S Zhao, K Washiyama, N Oriuchi, C Tan… - EJNMMI physics, 2020 - Springer
Background 211 At is one of the ideal nuclides for targeted radionuclide therapies (TRTs).
Meta-[ 211 At]astatobenzylguanidine ( 211 At-MABG) has been proposed for the treatment of …
Meta-[ 211 At]astatobenzylguanidine ( 211 At-MABG) has been proposed for the treatment of …